Nasaleze International, Ltd.
Isle of ManFDA applicant, unverified
- Devices
- 2
What Nasaleze International, Ltd. makes
Nasaleze International, Ltd. manufactures nasal allergy relief devices, including the AllerBlock Junior and Alzair Allergy Blocker, designed to reduce symptoms caused by airborne allergens.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
AllerBlock Junior Ref K201734
Regimes: 510(k) Registry: 510(k)Alzair Allergy Blocker Ref K170848
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Nasaleze International, Ltd. have in the registry?
The registry currently lists 2 devices for Nasaleze International, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Nasaleze International, Ltd.'s devices?
Among its 2 most recently registered devices, Nasaleze International, Ltd. has devices listed in FDA 510(k) (2 devices).
What risk classes do Nasaleze International, Ltd.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Nasaleze International, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Nasaleze International, Ltd. in the registry?
The most recently registered devices listed for Nasaleze International, Ltd. include AllerBlock Junior and Alzair Allergy Blocker.